Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 03 AUGUST 2020

AI In Focus: BlueDot And The Response To COVID-19

Smart & Biggar
Explore more from Smart & Biggar

The next application of Artificial Intelligence (AI) to be examined in our AI in Focus series is in the area of infectious disease monitoring, which is particularly relevant during the COVID-19...

CanadaIntellectual Property
Isi Caulder
Isi Caulder
Author LinkedIn connections

The next application of Artificial Intelligence (AI) to be examined in our AI in Focus series is in the area of infectious disease monitoring, which is particularly relevant during the COVID-19 pandemic.

Amid the global upheaval of COVID-19, artificial intelligence and data analytics are taking center stage for their ability to provide insights and solutions for managing the pandemic. As we discussed in an earlier article, innovative Canadian technology companies are being fueled by funding and investment opportunities and responding to urgent demands in the marketplace. Looking forward, we can expect both new AI startups, as well as existing data science companies looking to add AI technologies to their portfolio, to enter the healthcare technology space.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

When AI Meets Copyright: SOCAN v Suno And The Broader AI Copyright Landscape

The Society of Composers, Authors and Music Publishers of Canada has launched a landmark Federal Court claim against AI music platform Suno, alleging systematic copyright infringement on a massive scale. As Canadian courts prepare to address whether AI platforms can infringe existing copyrights and whether AI-generated works merit protection, these cases will establish critical precedents for how generative AI intersects with intellectual property law across all industries.
CanadaIntellectual Property
McMillan LLP
McMillan LLP
Article

Health Canada Updates Policies On Foreign Regulatory Actions, Summary Reporting, Compliance & Enforcement And Requests For New Data

Health Canada issued revised guidance on notifying Health Canada of foreign actions, effective October 1, 2026. The revised guidance clarifies the requirements to notify Health Canada of certain foreign regulatory actions specified in subsection C.01.050(2) of the Food and Drug Regulations in the specified foreign jurisdictions, which involve a serious risk of injury to human health and are relevant to the safety of the drug.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

Health Canada Obtains Permanent Injunction To Prevent Illegal Sale Of Injectable Peptides By Canlab Research

Health Canada has secured a permanent injunction against Canlab Research, a Quebec-based online retailer, preventing the company from manufacturing, distributing, or selling unauthorized injectable peptides in Canada. This enforcement action follows years of regulatory warnings and provisional court orders aimed at stopping the illegal sale of peptide drugs promoted with unproven health claims for anti-aging, weight loss, and athletic performance.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar